Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
1.
2.
Cardiol Young ; 34(7): 1600-1605, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38785339

RESUMO

We report the case of a female neonate admitted to the neonatal ICU with a rapid, narrow-complex tachyarrhythmia determined to be supraventricular tachycardia. Multimodality imaging and genetic testing confirmed a diagnosis of tuberous sclerosis complex with multiple cardiac rhabdomyomas. At 13 days of age, the patient was readmitted, exhibiting recurrent supraventricular tachycardia non-responsive to first-line treatment. Management required triple-drug therapy, whereafter the patient remained stable without recurrences. This is a rare report of supraventricular tachycardia in a functionally normal heart with the occurrence of supraventricular tachycardia due to structural abnormalities, with the possibility of multiple concealed accessory pathways.


Assuntos
Eletrocardiografia , Neoplasias Cardíacas , Rabdomioma , Taquicardia Supraventricular , Esclerose Tuberosa , Humanos , Esclerose Tuberosa/complicações , Esclerose Tuberosa/genética , Esclerose Tuberosa/diagnóstico , Feminino , Taquicardia Supraventricular/tratamento farmacológico , Taquicardia Supraventricular/etiologia , Taquicardia Supraventricular/diagnóstico , Recém-Nascido , Rabdomioma/complicações , Rabdomioma/tratamento farmacológico , Rabdomioma/diagnóstico , Rabdomioma/genética , Neoplasias Cardíacas/tratamento farmacológico , Neoplasias Cardíacas/complicações , Neoplasias Cardíacas/diagnóstico , Recidiva , Antiarrítmicos/uso terapêutico , Quimioterapia Combinada , Ecocardiografia
3.
Curr Opin Cardiol ; 39(4): 340-347, 2024 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-38606680

RESUMO

PURPOSE OF REVIEW: The aim of this study is to provide an update on mitral valve prolapse (MVP) and mitral annular disjunction (MAD) and who may be at risk for ventricular arrhythmias and sudden cardiac death. RECENT FINDINGS: MVP is generally considered a benign condition. However, a small subset of patients may be at risk for life-threatening ventricular arrhythmias. Among the risk factors identified in adults include patients with bileaflet mitral valves, myxomatous changes, myocardial fibrosis, and the presence of MAD. Advances in multimodal imaging have allowed for improved identification of fibrosis, anatomical valve derangements, and the amount of MAD. Recent guidelines have suggested that patients with MVP with or without MAD may be at risk for life-threatening arrhythmias if they have had prior ventricular arrhythmias, ventricular dysfunction, or unexplained syncope. Yet, extrapolation of adult data to a pediatric cohort with similar MVP and MAD at this juncture is challenging. There is, however, early evidence that some pediatric patients with significant myocardial fibrosis or abnormal tissue Doppler may be at risk for ventricular tachycardia. SUMMARY: Mitral valve prolapse and mitral annular disjunction at times coexist and at other times can be seen as isolated entities. While the incidence of arrhythmic MVP is quite rare, there is increasing evidence that certain select adults with MVP may be at risk for ventricular tachycardia and sudden cardiac death. Future multicenter studies are needed to better understand the natural history of arrhythmic mitral valve disease and how early disease manifestation in children may impact findings now being reported in young adults.


Assuntos
Prolapso da Valva Mitral , Valva Mitral , Humanos , Prolapso da Valva Mitral/complicações , Valva Mitral/diagnóstico por imagem , Valva Mitral/patologia , Adulto , Adolescente , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/epidemiologia , Fatores de Risco , Arritmias Cardíacas/etiologia
4.
A A Pract ; 18(2): e01721, 2024 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-38305709

RESUMO

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhythmogenic disorder characterized by episodes of polymorphic ventricular tachycardia. Clinically, patients who have CPVT present with juvenile sudden death or stress-induced syncope. We present a case of an 18-year-old girl with CPVT resistant to traditional pharmacotherapies. Instead of a typical stellate ganglion block (SGB), the patient underwent bilateral continuous proximal intercostal blocks that successfully inhibited arrhythmogenic events. This therapeutic method may provide an alternative to SGBs and demonstrates proof of concept for an early elective intervention to be included in the diagnostic and therapeutic algorithm for patients with CPVT.


Assuntos
Taquicardia Ventricular , Adolescente , Feminino , Humanos , Síncope/complicações , Síncope/diagnóstico , Taquicardia Ventricular/terapia
5.
Ann Thorac Surg ; 116(5): 871-907, 2023 11.
Artigo em Inglês | MEDLINE | ID: mdl-37777933

RESUMO

Care and outcomes for the more than 40,000 patients undergoing pediatric and congenital heart surgery in the United States annually are known to vary widely. While consensus recommendations have been published across numerous fields as one mechanism to promote a high level of care delivery across centers, it has been more than two decades since the last pediatric heart surgery recommendations were published in the United States. More recent guidance is lacking, and collaborative efforts involving the many disciplines engaged in caring for these children have not been undertaken to date. The present initiative brings together professional societies spanning numerous care domains and congenital cardiac surgeons, pediatric cardiologists, nursing, and other healthcare professionals from diverse programs around the country to develop consensus recommendations for United States centers. The focus of this initial work is on pediatric heart surgery, and it is recommended that future efforts focus in detail on the adult congenital population. We describe the background, rationale, and methodology related to this collaborative effort, and recommendations put forth for Essential Care Centers (essential services necessary for any program), and Comprehensive Care Centers (services to optimize comprehensive and high-complexity care), encompassing structure, process, and outcome metrics across 14 domains.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cardiopatias Congênitas , Adulto , Humanos , Criança , Estados Unidos , Cardiopatias Congênitas/cirurgia , Cardiopatias Congênitas/etiologia , Procedimentos Cirúrgicos Cardíacos/métodos , Atenção à Saúde
6.
J Thorac Cardiovasc Surg ; 166(6): 1782-1820, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37777958

RESUMO

Care and outcomes for the more than 40,000 patients undergoing pediatric and congenital heart surgery in the United States annually are known to vary widely. While consensus recommendations have been published across numerous fields as one mechanism to promote a high level of care delivery across centers, it has been more than two decades since the last pediatric heart surgery recommendations were published in the United States. More recent guidance is lacking, and collaborative efforts involving the many disciplines engaged in caring for these children have not been undertaken to date. The present initiative brings together professional societies spanning numerous care domains and congenital cardiac surgeons, pediatric cardiologists, nursing, and other healthcare professionals from diverse programs around the country to develop consensus recommendations for United States centers. The focus of this initial work is on pediatric heart surgery, and it is recommended that future efforts focus in detail on the adult congenital population. We describe the background, rationale, and methodology related to this collaborative effort, and recommendations put forth for Essential Care Centers (essential services necessary for any program), and Comprehensive Care Centers (services to optimize comprehensive and high-complexity care), encompassing structure, process, and outcome metrics across 14 domains.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cardiopatias Congênitas , Adulto , Humanos , Criança , Estados Unidos , Cardiopatias Congênitas/cirurgia , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Atenção à Saúde , Consenso
7.
World J Pediatr Congenit Heart Surg ; 14(5): 642-679, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37737602

RESUMO

Care and outcomes for the more than 40,000 patients undergoing pediatric and congenital heart surgery in the United States annually are known to vary widely. While consensus recommendations have been published across numerous fields as one mechanism to promote a high level of care delivery across centers, it has been more than two decades since the last pediatric heart surgery recommendations were published in the United States. More recent guidance is lacking, and collaborative efforts involving the many disciplines engaged in caring for these children have not been undertaken to date. The present initiative brings together professional societies spanning numerous care domains and congenital cardiac surgeons, pediatric cardiologists, nursing, and other healthcare professionals from diverse programs around the country to develop consensus recommendations for United States centers. The focus of this initial work is on pediatric heart surgery, and it is recommended that future efforts focus in detail on the adult congenital population. We describe the background, rationale, and methodology related to this collaborative effort, and recommendations put forth for Essential Care Centers (essential services necessary for any program), and Comprehensive Care Centers (services to optimize comprehensive and high-complexity care), encompassing structure, process, and outcome metrics across 14 domains.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cirurgiões , Adulto , Humanos , Criança , Coração
8.
Cardiol Young ; 33(8): 1277-1287, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37615116

RESUMO

The Eighth World Congress of Pediatric Cardiology and Cardiac Surgery (WCPCCS) will be held in Washington DC, USA, from Saturday, 26 August, 2023 to Friday, 1 September, 2023, inclusive. The Eighth World Congress of Pediatric Cardiology and Cardiac Surgery will be the largest and most comprehensive scientific meeting dedicated to paediatric and congenital cardiac care ever held. At the time of the writing of this manuscript, The Eighth World Congress of Pediatric Cardiology and Cardiac Surgery has 5,037 registered attendees (and rising) from 117 countries, a truly diverse and international faculty of over 925 individuals from 89 countries, over 2,000 individual abstracts and poster presenters from 101 countries, and a Best Abstract Competition featuring 153 oral abstracts from 34 countries. For information about the Eighth World Congress of Pediatric Cardiology and Cardiac Surgery, please visit the following website: [www.WCPCCS2023.org]. The purpose of this manuscript is to review the activities related to global health and advocacy that will occur at the Eighth World Congress of Pediatric Cardiology and Cardiac Surgery.Acknowledging the need for urgent change, we wanted to take the opportunity to bring a common voice to the global community and issue the Washington DC WCPCCS Call to Action on Addressing the Global Burden of Pediatric and Congenital Heart Diseases. A copy of this Washington DC WCPCCS Call to Action is provided in the Appendix of this manuscript. This Washington DC WCPCCS Call to Action is an initiative aimed at increasing awareness of the global burden, promoting the development of sustainable care systems, and improving access to high quality and equitable healthcare for children with heart disease as well as adults with congenital heart disease worldwide.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cardiologia , Cardiopatias , Adulto , Criança , Humanos
9.
Curr Opin Cardiol ; 38(4): 380-384, 2023 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-37115857

RESUMO

PURPOSE OF REVIEW: The purpose of this review is to move beyond measures to improve individual resilience but to focus on measures to achieve better team resilience. RECENT FINDINGS: The COVID pandemic, shortages of heath care workers, and subsequent viral resurgence in 2022 placed tremendous stress on pediatric healthcare systems. Much has been written about individual wellness, mindfulness, and strategies to be a more resilient individual. However, little has been written on the importance of team resilience. Resilient teams work together to overcome daily stressors and challenges. Although leaders must create and foster a collaborative culture to establish cohesive and resilient teams; it also requires tremendous institutional support. Four key factors have emerged with regards to successful team resilience: candor, humility, resourcefulness, and compassion and empathy. This article discusses the key elements required for resilient teams to not only survive but also to thrive. SUMMARY: Effective heart centers, like the symphony, are a collection of individuals all coming together to care for a child or create a singular piece of music. Heart centers without effective leaders will most certainly fail, but even with the most accomplished and passionate leaders, there must be administrative institutional support and a shared vision.


Assuntos
COVID-19 , Resiliência Psicológica , Humanos , Criança , COVID-19/epidemiologia , Pessoal de Saúde , Pandemias , Empatia
12.
J Am Coll Cardiol ; 80(23): 2224-2238, 2022 12 06.
Artigo em Inglês | MEDLINE | ID: mdl-36456053

RESUMO

Together, heart failure and arrhythmia represent the most important cardiovascular sources of morbidity and mortality among adults with congenital heart disease (ACHDs). Although traditionally conceptualized as operating within 2 distinct clinical silos, these scenarios frequently coexist within the same individual; consequently the mechanistic, therapeutic, and prognostic overlap between them demands increased recognition. In fact, given the near ubiquity of heart failure and arrhythmia among ACHDs, there is perhaps no other arena within cardiology where this critical intersection is more frequently observed. Optimal care for ACHDs therefore requires a heightened awareness of the relevant interactions as well as the pharmacologic and interventional resources that are increasingly available to the treating cardiologist. This review explores and highlights the overlap between these 2 fields to recommend a parallel, yet interactive, multidisciplinary approach to clinical management. Congenital heart disease categories are broken down into their archetypal subtypes to highlight subtleties of the pathophysiology, evaluation, and therapeutic approach.


Assuntos
Cardiologistas , Cardiologia , Cardiopatias Congênitas , Insuficiência Cardíaca , Adulto , Humanos , Arritmias Cardíacas/etiologia , Arritmias Cardíacas/terapia , Cardiopatias Congênitas/complicações , Cardiopatias Congênitas/terapia , Insuficiência Cardíaca/complicações , Insuficiência Cardíaca/terapia
13.
Curr Opin Pediatr ; 34(5): 476-483, 2022 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-36000387

RESUMO

PURPOSE OF REVIEW: The purpose of this review is to explore the historical and serendipitous events that led to the creation of modern-day pacemakers. In addition, this review will explore how contemporary conduction site-specific pacing has overcome some of the deleterious effects from historical chronic right ventricular apical pacing. RECENT FINDINGS: Recently, there have been tremendous advances in not just the lead design but the tools required to promote more physiologic pacing. Although cardiac resynchronization pacing has been around for nearly 2 decades, this review also introduces and discusses the early results of His-bundle pacing and left bundle branch pacing and some of the potential applicability of this technology for our children. SUMMARY: Pacemakers have evolved significantly in the last 30 years through collaborative partnerships between physicians and engineers. The future of cardiac pacing is bright compared to the field of electrotherapy 50 years ago. Future iterations of pacemakers must consider unusual anatomy and growing children. Pediatric patients contribute to a small percentage of the overall device volume, but the majority of these patients will have a pacemaker for life. We need to be proactive and consider what are the best short and long-term solutions for this cohort.


Assuntos
Fascículo Atrioventricular , Estimulação Cardíaca Artificial , Estimulação Cardíaca Artificial/métodos , Criança , Eletrocardiografia/métodos , Previsões , Humanos , Resultado do Tratamento
14.
Pediatr Cardiol ; 43(8): 1898-1902, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35661239

RESUMO

The objective of this study is to determine the prevalence of an abnormal electrocardiogram showing a prolonged QTc greater than 450 ms in infants with unilateral or bilateral sensorineural hearing loss. We conducted a prospective study of healthy term infants (≥37 weeks gestational age) who failed their newborn auditory brainstem response hearing screen, were seen by an audiologist and diagnosed as having sensorineural hearing loss during follow-up to 1 year of age. In infants with a diagnosis of hearing loss, we collected a detailed family history and performed an ECG between 2 and 6 months of age. We obtained follow-up for 1 year by calling the parent requesting the hearing and cardiac status of their child. Two of the 40 infants with sensorineural hearing loss (5%) had a QTc greater than 450 ms. Both had mild bilateral hearing loss and genetic testing did not identify a known mutation for long QT syndrome. The remaining 38 infants had QTc intervals of ≤ 450 ms. One patient diagnosed with bilateral severe sensorineural hearing loss had a normal ECG (QTc = 417 ms). Several months after the ECG was performed, the infant's mother contacted the study cardiologist after she learned that the infant's maternal grandmother was diagnosed with a cardiomyopathy and arrhythmias. Genetic testing was recommended even though the child was asymptomatic and was positive for a pathogenic mutation in the KCNQ1 gene. We speculate that molecular genetic testing in infants with hearing loss may become the standard of care rather than targeted electrocardiograms.Clinical Trial Registration NCT02082431 https://www.clinicaltrials.gov/ct2/show/NCT02692521?cond=NCT02692521&rank=1 .


Assuntos
Perda Auditiva Neurossensorial , Perda Auditiva , Síndrome do QT Longo , Lactente , Recém-Nascido , Criança , Feminino , Humanos , Estudos Prospectivos , Canal de Potássio KCNQ1 , Síndrome do QT Longo/diagnóstico , Síndrome do QT Longo/epidemiologia , Síndrome do QT Longo/genética , Perda Auditiva/diagnóstico , Perda Auditiva/epidemiologia , Perda Auditiva/genética , Perda Auditiva Neurossensorial/diagnóstico , Perda Auditiva Neurossensorial/epidemiologia , Perda Auditiva Neurossensorial/genética , Sistema de Registros
15.
Cardiol Young ; 32(12): 1989-1993, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35362403

RESUMO

BACKGROUND: The Pediatric and Congenital Electrophysiology Society (PACES) is a global organisation committed to the care of children and adults with CHD and arrhythmias. OBJECTIVE: To evaluate the global needs and potential inequities as it relates to cardiac implantable electronic devices. METHODS: ARROW (Assessment of Rhythm Resources arOund the World) is an online survey about cardiac implantable electronic devices, sent electronically to physicians within the field of Cardiology, Pediatric Cardiology, Electrophysiology and Pediatric Electrophysiology. RESULTS: ARROW received 42 responders from 28 countries, 50% from low-/middle-income regions. The main differences between low-/middle- and high-income regions include availability of expertise on paediatric electrophysiology (50% versus 93%, p < 00.5) and possibility to perform invasive procedures (35% versus 93%, p < 0.005). Implant of devices in low-income areas relies significantly on patient's resources (71%). The follow-up of the devices is on the hands of paediatric cardiologist/electrophysiologist in higher resources centres (93% versus 50%, p < 0.05). CONCLUSIONS: The ARROW survey represents an initial assessment of the geographical characteristics in the field of Pediatric Electrophysiology. The next step is to make this "state of the art" more extensive to other aspects of the expertise. The relevance of collecting this data before the World Congress of Pediatric Cardiology and Cardiac Surgery (WCPCCS) in 2023 in Washington DC was emphasised in order to share the resulting information with the international community and set a plan of action to assist the development of arrhythmia services for children within developing regions of the world.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Cardiologia , Desfibriladores Implantáveis , Adulto , Criança , Humanos , Eletrofisiologia Cardíaca , Arritmias Cardíacas/terapia , Eletrônica
16.
Curr Opin Cardiol ; 37(1): 99-108, 2022 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-34857718

RESUMO

PURPOSE OF REVIEW: Review the current state of the art of arrhythmogenic right ventricular cardiomyopathy (ARVC) diagnosis and risk stratification in the pediatric population. RECENT FINDINGS: ARVC is an inherited cardiomyopathy characterized by progressive myocyte loss and fibrofatty replacement of predominantly the right ventricle and high risk of ventricular arrhythmias and sudden cardiac death (SCD). ARVC is one of the leading causes of arrhythmic cardiac arrest in young people. Early diagnosis and accurate risk assessment are challenging, especially in children who often exhibit little to no phenotype, even if genotype positive. Multimodal imaging provides more detailed assessment of the right ventricle and has been shown in pediatric patients to identify earlier preclinical disease expression. Identification of patients with ARVC allows the clinician to intervene early with appropriate exercise restrictions, even if genotype positive only without phenotypic expression. Emphasis should be placed on stratifying the patient's risk of ventricular arrhythmias and SCD. SUMMARY: ARVC is a challenging diagnosis to make in adolescents who often do not exhibit clinical symptoms. Newer multimodal imaging techniques and improvements in genetic testing and biomarkers should help improve early diagnosis. Exercise restriction for children with ARVC has been shown to reduce disease advancement and decreases the risk of a life-threatening event.


Assuntos
Displasia Arritmogênica Ventricular Direita , Cardiomiopatias , Adolescente , Arritmias Cardíacas/epidemiologia , Displasia Arritmogênica Ventricular Direita/diagnóstico , Displasia Arritmogênica Ventricular Direita/genética , Displasia Arritmogênica Ventricular Direita/terapia , Criança , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/prevenção & controle , Humanos , Medição de Risco/métodos
19.
JACC Clin Electrophysiol ; 7(11): 1437-1472, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34794667

RESUMO

In view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories. The document also highlights variations between previously published adult and pediatric CIED recommendations and provides rationale for underlying important differences. The document addresses some of the deterrents to CIED access in low- and middle-income countries and strategies to circumvent them. The document sections were divided up and drafted by the writing committee members according to their expertise. The recommendations represent the consensus opinion of the entire writing committee, graded by class of recommendation and level of evidence. Several questions addressed in this document either do not lend themselves to clinical trials or are rare disease entities, and in these instances recommendations are based on consensus expert opinion. Furthermore, specific recommendations, even when supported by substantial data, do not replace the need for clinical judgment and patient-specific decision-making. The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating committee of the American Heart Association (AHA), the American College of Cardiology (ACC), and the Association for European Paediatric and Congenital Cardiology (AEPC). The document received endorsement by all the collaborators and the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). This document is expected to provide support for clinicians and patients to allow for appropriate CIED use, appropriate CIED management, and appropriate CIED follow-up in pediatric patients.


Assuntos
Cardiologia , Desfibriladores Implantáveis , Adulto , American Heart Association , Criança , Eletrônica , Humanos , América Latina , Estados Unidos
20.
JACC Case Rep ; 3(16): 1736-1737, 2021 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-34825199
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA